Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 5 (2008), Issue 6 (June)

1. C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes.
   Biochem Pharmacol, 75(12): 2325-33. [Abstract] [Full-text]
2. Simultaneous determination of cell aging and ATP release from erythrocytes and its implications in type 2 diabetes.
   Anal Chim Acta, 618(2): 227-33. [Abstract] [Full-text]
3. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.
   Ophthalmology, 115(6): e21-5. [Abstract] [Full-text]
4. Diabetes and the tortuosity of vessels of the bulbar conjunctiva.
   Ophthalmology, 115(6): e27-32. [Abstract] [Full-text]
5. Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study.
   Ophthalmology, 115(6): 964-968.e1. [Abstract] [Full-text]
6. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.
   Ann Surg, 247(6): 968-75. [Abstract] [Full-text]
7. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
   Hepatology, 47(6): 1856-62. [Abstract] [Full-text]
8. Patient-important outcomes in registered diabetes trials.
   JAMA, 299(21): 2543-9. [Abstract] [Full-text]
9. A 40-year-old woman with diabetes contemplating pregnancy after gastric bypass surgery.
   JAMA, 299(21): 2550-7. [Abstract] [Full-text]
10. Has time come for new goals in human islet transplantation?
    Am J Transplant, 8(6): 1096-100. [Abstract] [Full-text]
11. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance.
    Am J Transplant, 8(6): 1262-74. [Abstract] [Full-text]
12. Islet transplantation for brittle type 1 diabetes: the UIC protocol.
    Am J Transplant, 8(6): 1250-61. [Abstract] [Full-text]
13. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats.
    Nat Med (Tokyo), 62(3): 284-93. [Abstract] [Full-text]
14. Aliskiren combined with losartan in type 2 diabetes and nephropathy.
    N Engl J Med, 358(23): 2433-46. [Abstract] [Full-text]
15. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.
    BMC Med Genet, 9: 45. [Abstract] [Full-text]
16. The prevalence of a diabetic condition and adhesive capsulitis of the shoulder.
    South Med J, 101(6): 591-5. [Abstract] [Full-text]
17. Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive.
    South Med J, 101(6): 606-11. [Abstract] [Full-text]
18. Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children.
    Arch Pediatr Adolesc Med, 162(6): 544-9. [Abstract] [Full-text]
19. Diabetes mellitus-related morphoquantitative changes in the celiac ganglion neurons of the dog.
    Vet J, 177(1): 54-62. [Abstract] [Full-text]
20. Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes.
    BMC Med Genet, 9: 42. [Abstract] [Full-text]
21. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.
    Circ Res, 102(11): 1416-25. [Abstract] [Full-text]
22. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
    J Am Coll Cardiol, 51(23): 2220-7. [Abstract] [Full-text]
23. Advances in type I diabetes associated tolerance mechanisms.
    Scand J Immunol, 68(1): 1-11. [Abstract] [Full-text]
24. Evidence for de novo expression of thymic insulin by peripheral bone marrow-derived cells.
    Scand J Immunol, 68(1): 67-74. [Abstract] [Full-text]
25. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.
    Lancet, 371(9628): 1927-35. [Abstract] [Full-text]
26. Diabetic control and risk of tuberculosis: a cohort study.
    Am J Epidemiol, 167(12): 1486-94. [Abstract] [Full-text]
27. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.
    Eur J Pain, 12(6): 804-13. [Abstract] [Full-text]
28. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
    Clin Chim Acta, 394(1): 99-103. [Abstract] [Full-text]
29. Inhibition of ROS production in peripheral blood mononuclear cells from type 2 diabetic patients by autologous plasma depends on Akt/PKB signaling pathway.
    Clin Chim Acta, 394(1): 77-80. [Abstract] [Full-text]
30. Physician performance and racial disparities in diabetes mellitus care.
    Arch Intern Med, 168(11): 1145-51. [Abstract] [Full-text]
31. Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4.
    Food Chem Toxicol, 46(7): 2554-60. [Abstract] [Full-text]
32. Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats.
    Food Chem Toxicol, 46(7): 2376-83. [Abstract] [Full-text]
33. Evaluation of the association between the common E469K polymorphism in the ICAM-1 gene and diabetic nephropathy among type 1 diabetic patients in GoKinD population.
    BMC Med Genet, 9: 47. [Abstract] [Full-text]
34. A novel association of a polymorphism in the first intron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia in Asian Indians.
    Hum Genet, 123(6): 599-605. [Abstract] [Full-text]
35. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.
    Diabetes Res Clin Pract, 81(1): 2-12. [Abstract] [Full-text]
36. The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy.
    Diabetes Res Clin Pract, 81(1): 25-32. [Abstract] [Full-text]
37. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Diabetes Res Clin Pract, 81(1): 117-23. [Abstract] [Full-text]
38. HbA1c negatively correlates with LCAT activity in type 2 diabetes.
    Diabetes Res Clin Pract, 81(1): 38-41. [Abstract] [Full-text]
39. Enterococcus gallinarum endocarditis in a diabetic patient.
    Diabetes Res Clin Pract, 81(1): e18-20. [Abstract] [Full-text]
40. Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus.
    Diabetes Res Clin Pract, 81(1): 124-9. [Abstract] [Full-text]
41. Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy.
    Diabetes Res Clin Pract, 81(1): e4-7. [Abstract] [Full-text]
42. Lack of knowledge of glycosylated hemoglobin in patients with diabetic retinopathy.
    Diabetes Res Clin Pract, 81(1): e15-7. [Abstract] [Full-text]
43. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus.
    Diabetes Res Clin Pract, 81(1): e8-11. [Abstract] [Full-text]
44. The angiotensin converting enzyme insertion/deletion polymorphism and differences in fasting plasma glucose in Hindustani Surinamese, African Surinamese and ethnic Dutch: the population-based SUNSET-study.
    Diabetes Res Clin Pract, 81(1): e12-4. [Abstract] [Full-text]
45. The haplotype identified in LEPR gene is associated with type 2 diabetes mellitus in Northern Chinese.
    Diabetes Res Clin Pract, 81(1): 33-7. [Abstract] [Full-text]
46. Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes.
    Diabetes Res Clin Pract, 81(1): 110-6. [Abstract] [Full-text]
47. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Diabetes Res Clin Pract, 81(1): e1-3. [Abstract] [Full-text]
48. The accuracy of population health data for monitoring trends and outcomes among women with diabetes in pregnancy.
    Diabetes Res Clin Pract, 81(1): 105-9. [Abstract] [Full-text]
49. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis.
    J Virol, 82(13): 6139-49. [Abstract] [Full-text]
50. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review.
    Diabetes Res Clin Pract, 81(1): 79-87. [Abstract] [Full-text]
51. Cardiovascular events and insulin therapy: a retrospective cohort analysis.
    Diabetes Res Clin Pract, 81(1): 97-104. [Abstract] [Full-text]
52. Analysis of muscle microcirculation in advanced diabetes mellitus by contrast enhanced ultrasound.
    Diabetes Res Clin Pract, 81(1): 88-92. [Abstract] [Full-text]
53. Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy.
    Diabetes Res Clin Pract, 81(1): 93-6. [Abstract] [Full-text]
54. Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.
    Diabetes Res Clin Pract, 81(1): 42-9. [Abstract] [Full-text]
55. Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications.
    Diabetes Res Clin Pract, 81(1): 61-7. [Abstract] [Full-text]
56. Improvements in HbA1c remain after 5 years--a follow up of an educational intervention focusing on patients' personal understandings of type 2 diabetes.
    Diabetes Res Clin Pract, 81(1): 50-5. [Abstract] [Full-text]
57. Dietary breads: myth or reality?
    Diabetes Res Clin Pract, 81(1): 68-71. [Abstract] [Full-text]
58. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.
    Diabetes Res Clin Pract, 81(1): 56-60. [Abstract] [Full-text]
59. Effects of intensive glucose lowering in type 2 diabetes.
    N Engl J Med, 358(24): 2545-59. [Abstract] [Full-text]
60. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
    N Engl J Med, 358(24): 2560-72. [Abstract] [Full-text]
61. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population.
    Am J Cardiol, 101(12): 1787-91. [Abstract] [Full-text]
62. A national study on lipid management.
    Eur J Intern Med, 19(5): 356-61. [Abstract] [Full-text]
63. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study.
    BMJ, 336(7657): 1348-51. [Abstract] [Full-text]
64. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
    Arch Biochem Biophys, 475(2): 128-34. [Abstract] [Full-text]
65. Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding?
    Physiol Genomics, 34(1): 1-5. [Abstract] [Full-text]
66. A meta-analysis of QTL for diabetes-related traits in rodents.
    Physiol Genomics, 34(1): 42-53. [Abstract] [Full-text]
67. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Metabolism, 57(7): 954-60. [Abstract] [Full-text]
68. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metabolism, 57(7): 946-53. [Abstract] [Full-text]
69. Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus.
    Metabolism, 57(7): 940-5. [Abstract] [Full-text]
70. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.
    Metabolism, 57(7): 873-81. [Abstract] [Full-text]
71. Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease.
    Clin Biochem, 41(10): 863-8. [Abstract] [Full-text]
72. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance.
    Clin Biochem, 41(10): 812-7. [Abstract] [Full-text]
73. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans.
    JAMA, 299(23): 2770-6. [Abstract] [Full-text]
74. Examining a bidirectional association between depressive symptoms and diabetes.
    JAMA, 299(23): 2751-9. [Abstract] [Full-text]
75. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds.
    J Histochem Cytochem, 56(7): 687-96. [Abstract] [Full-text]
76. Proteinuria in diabetic kidney disease: a mechanistic viewpoint.
    Kidney Int, 74(1): 22-36. [Abstract] [Full-text]
77. Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney.
    Kidney Int, 74(1): 91-100. [Abstract] [Full-text]
78. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?
    Obes Rev, 9(4): 312-25. [Abstract] [Full-text]
79. Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats.
    J Pharmacol Exp Ther, 326(1): 323-9. [Abstract] [Full-text]
80. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Arterioscler Thromb Vasc Biol, 28(7): 1225-36. [Abstract] [Full-text]
81. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
    Hypertension, 52(1): 130-6. [Abstract] [Full-text]
82. Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation.
    Clin Immunol, 128(1): 23-30. [Abstract] [Full-text]
83. Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes.
    Clin Immunol, 128(1): 57-65. [Abstract] [Full-text]
84. Complicated acute appendicitis in diabetic patients.
    Am J Surg, 196(1): 34-9. [Abstract] [Full-text]
85. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
    J Am Coll Cardiol, 51(25): 2385-95. [Abstract] [Full-text]
86. Evidence-based emergency medicine/critically appraised topic. Is fluid therapy associated with cerebral edema in children with diabetic ketoacidosis?
    Ann Emerg Med, 52(1): 69-75.e1. [Abstract] [Full-text]
87. Inaccurate hemoglobin A(1C) levels in patients with type 1 diabetes and hereditary persistence of hemoglobin F.
    J Pediatr, 153(1): 137-9. [Abstract] [Full-text]
88. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
    J Pediatr, 153(1): 122-6. [Abstract] [Full-text]
89. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
    Autoimmunity, 41(5): 383-94. [Abstract] [Full-text]
90. Muscle compromise in diabetes.
    Acta Radiol, 49(6): 673-9. [Abstract] [Full-text]
91. The prevention of type 2 diabetes.
    Nat Clin Pract Endocrinol Metab, 4(7): 382-93. [Abstract] [Full-text]
92. Nephrogenic diabetes insipidus in a patient with L1 syndrome: a new report of a contiguous gene deletion syndrome including L1CAM and AVPR2.
    Am J Med Genet A, 146(14): 1853-8. [Abstract] [Full-text]
93. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
    Eur J Endocrinol, 159(1): 19-26. [Abstract] [Full-text]
94. Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor rats.
    Mol Ther, 16(7): 1235-42. [Abstract] [Full-text]
95. Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome.
    J Comp Neurol, 509(6): 642-60. [Abstract] [Full-text]
96. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
    Anesthesiology, 109(1): 14-24. [Abstract] [Full-text]
97. Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy.
    J Neurosci, 28(26): 6652-8. [Abstract] [Full-text]
98. Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.
    Invest Ophthalmol Vis Sci, 49(7): 3231-8. [Abstract] [Full-text]
99. TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy.
    Invest Ophthalmol Vis Sci, 49(7): 3151-7. [Abstract] [Full-text]
100. Prospective 2-years follow-up quality of life study after infrageniculate bypass surgery for limb salvage: lasting improvements only in non-diabetic patients.
     Eur J Vasc Endovasc Surg, 36(1): 63-70. [Abstract] [Full-text]
101. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
     Urol Int, 80(4): 378-82. [Abstract] [Full-text]
102. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts.
     Diabetes, 57(7): 1978-82. [Abstract] [Full-text]
103. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes.
     Diabetes, 57(7): 1759-67. [Abstract] [Full-text]
104. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
     Am Heart J, 156(1): 125-34. [Abstract] [Full-text]
105. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
     Am Heart J, 156(1): 57-64. [Abstract] [Full-text]
106. Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.
     Cardiovasc Diabetol, 7: 20. [Abstract] [Full-text]
107. Urinary proteomics in diabetes and CKD.
     J Am Soc Nephrol, 19(7): 1283-90. [Abstract] [Full-text]
108. Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians.
     Diabetes, 57(7): 1992-6. [Abstract] [Full-text]
109. Association analysis of type 2 diabetes Loci in type 1 diabetes.
     Diabetes, 57(7): 1983-6. [Abstract] [Full-text]
110. RAGE and modulation of ischemic injury in the diabetic myocardium.
     Diabetes, 57(7): 1941-51. [Abstract] [Full-text]
111. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
     Diabetes, 57(7): 1861-9. [Abstract] [Full-text]
112. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling.
     Diabetes, 57(7): 1805-13. [Abstract] [Full-text]
113. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.
     Diabetes, 57(7): 1878-86. [Abstract] [Full-text]
114. Plasma C5 glucose-to-2H2O ratio does not provide an accurate assessment of gluconeogenesis during hyperinsulinemic-euglycemic clamps in either nondiabetic or diabetic humans.
     Diabetes, 57(7): 1800-4. [Abstract] [Full-text]
115. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.
     Diabetes, 57(7): 1852-60. [Abstract] [Full-text]
116. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy.
     Diabetes, 57(7): 1966-70. [Abstract] [Full-text]
117. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence.
     Diabetes, 57(7): 1935-40. [Abstract] [Full-text]
118. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.
     Diabetes, 57(7): 1905-17. [Abstract] [Full-text]
119. Sirolimus is associated with new-onset diabetes in kidney transplant recipients.
     J Am Soc Nephrol, 19(7): 1411-8. [Abstract] [Full-text]
120. Detection of global glycosylation changes of serum proteins in type 1 diabetes using a lectin panel and multivariate data analysis.
     Talanta, 76(2): 333-7. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.